Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-017787
Filing Date
2025-07-03
Accepted
2025-07-03 16:05:22
Documents
1
Period of Report
2025-07-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3472
  Complete submission text file 0001641172-25-017787.txt   5158
Mailing Address 3420 CENTRAL EXPRESSWAY SANTA CLARA CA 95051
Business Address
Last Andrew J. (Reporting) CIK: 0001485088 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37648 | Film No.: 251105558

Mailing Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217
Business Address 2 INTERNATIONAL PLAZA DR., SUITE 510 NASHVILLE TN 37217 949-409-7600
Insight Molecular Diagnostics Inc. (Issuer) CIK: 0001642380 (see all company filings)

EIN.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)